Frederick L. Hall

4.8k citations

104 papers · 4.0k indexed · h-index 39

Impact in

Oncology top 2%
- Cancer-related Molecular Pathways
Cell Biology top 2%
- Microtubule and mitosis dynamics

Papers in

Oncology 42
- Cancer-related Molecular Pathways 27
Biotechnology 12
- Cancer Research and Treatments 12

Co-authors: Erlinda M. Gordon Philip R Vulliet Richard T. Williams Lingtao Wu D. A. Carbonaro-Hall W. French Anderson Kim L. O’Neill M Torres
Journals: Human Gene Therapy (9 papers)Journal of Biological Chemistry (8 papers)International Journal of Molecular Medicine (4 papers)International Journal of Oncology (3 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: United States France Spain

In The Last Decade

Frederick L. Hall

99 papers receiving 3.8k citations

Peers

Countries citing papers authored by Frederick L. Hall

Since Specialization

Citations

This map shows the geographic impact of Frederick L. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick L. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick L. Hall more than expected).

Fields of papers citing papers by Frederick L. Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick L. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick L. Hall. The network helps show where Frederick L. Hall may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frederick L. Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick L. Hall Line = papers co-authored together Frederick L. Hall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gene and Cell Therapy for Sarcomas: A Review Cancers ·Sant P. Chawla, Stephen C. Pang, Dhawal Jain, Meihui Zhao, Neal Shiv Chawla, Paul Y. Song, Frederick L. Hall, Erlinda M. Gordon	2025	0
2	Early-stage CCNG1+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a CCNG1 Inhibitor Anticancer Research ·Sant P. Chawla, Gery Alaerts, Geeta S. Iyengar, Людмила Павловна Гербер, Jiu Haifeng, W Erking, Kushal Suryamohan, Leland J. Foshag, Frederick L. Hall, Erlinda M. Gordon	2023	1
3	Larkin: FDA Emergency Use Authorized Treatment Protocol of DeltaRex-G for Severe Covid-19 [IND# 27185] S. Bucknor, George Michel, 宏樹長澤, H. N. Tyssøy, MathiasT. C Egri Okwaji, Людмила Павловна Гербер, Sant P. Chawla, Frederick L. Hall, Erlinda M. Gordon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2021	1
4	CCNG1 oncogene: a novel biomarker for cancer therapy /gene therapy Erlinda M. Gordon, Hao-Yi Syu, Sant P. Chawla, Christopher W. Szeto, Michael A. Morse, Frederick L. Hall	2021	1
5	Rexin-G®, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report Molecular and Clinical Oncology ·Clara Torres Delafue, Noah Federman, Erlinda M. Gordon, Frederick L. Hall, Sant P. Chawla	2017	24
6	Ligand-Modified Vesicular Stomatitis Virus Glycoprotein Displays a Temperature-Sensitive Intracellular Trafficking and Virus Assembly Phenotype Molecular Therapy ·Ghiabe-Henri Guibinga, Frederick L. Hall, Erlinda M. Gordon, Erkki Ruoslahti, Theodore Friedmann	2003	24
7	Phenotypic Differentiation of TGF-β1-Responsive Pluripotent Premesenchymal Prehematopoietic Progenitor (P4 Stem) Cells from Murine Bone Marrow Journal of Hematotherapy & Stem Cell Research ·Frederick L. Hall, Bo Han, Ramendra K. Kundu, Ann Yee, Marcel E. Nimni, Erlinda M. Gordon	2001	25
8	The MAT1 cyclin‐dependent kinase‐activating kinase (CAK) assembly/targeting factor interacts physically with the MCM7 DNA licensing factor FEBS Letters ·Yan Wang, Fan Xu, Frederick L. Hall	2000	11
9	Refolding of a Recombinant Collagen-Targeted TGF-β2 Fusion Protein Expressed inEscherichia coli Protein Expression and Purification ·Bo Han, Frederick L. Hall, Marcel E. Nimni	1997	28
10	Retroviral Vector-Mediated Transfer of an Antisense Cyclin G1 Construct Inhibits Osteosarcoma Tumor Growth in Nude Mice Human Gene Therapy ·Daniel S. Chen, Nian‐Ling Zhu, Gene Hung, Lorna Gordon, David R. Hinton, Vernon T. Tolo, Frederick L. Hall, W. French Anderson, Erlinda M. Gordon	1997	39
11	Type I collagen combined with a recombinant TGF-beta serves as a scaffold for mesenchymal stem cells The International Journal of Developmental Biology ·José A. Andrades, Marcel E. Nimni, Bo Han, Delia Ertl, Frederick L. Hall, José Becerra	1996	10
12	Abrogation of Transforming Growth Factor-β Type II Receptor Stimulates Embryonic Mouse Lung Branching Morphogenesis in Culture Developmental Biology ·Jingsong Zhao, Ding Fang Bu, Matt Lee, Harold C. Slavkin, Frederick L. Hall, David Warburton	1996	87
13	Characterization of Protein Kinases Involved in Dentinogenesis Connective Tissue Research ·M Zeichner‐David, Frederick L. Hall, Richard Williams, Flávia Torreão Thiemann, Stephen Yen, Mary MacDougall, H.C. Slavkin	1995	6
14	Identification, Assay, and Purification of a Cdc2-Activating Threonine-161 Protein Kinase from Human-Cells Archives of Biochemistry and Biophysics ·R. T. Williams, Li Wu, D. A. Carbonaro-Hall, Frederick L. Hall	1994	2
15	Cyclin A Expression in Normal and Transformed Alveolar Epithelial Cells American Journal of Respiratory Cell and Molecular Biology ·Kim Chi Bui, Frank Wu, A. Fritz Wilson, Lingtao Wu, Richard T. Williams, D. A. Carbonaro-Hall, Frederick L. Hall, David Warburton	1993	18
16	An FKBP‐Rapamycin‐Sensitive, Cyclin‐Dependent Kinase Activity that Correlates with the FKBP‐Rapamycin‐Induced G1 Arrest Point in MG‐63 Cells^a Annals of the New York Academy of Sciences ·Mark W. Albers, Eric J. Brown, Akito Tanaka, Richard T. Williams, Frederick L. Hall, Stuart L. Schreiber	1993	14
17	FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. Journal of Biological Chemistry ·Mark W. Albers, Richard T. Williams, Eric J. Brown, Angela Pittman, Frederick L. Hall, S.L. Schreiber	1993	128
18	Epigenetic role of epidermal growth factor expression and signalling in embryonic mouse lung morphogenesis Developmental Biology ·David Warburton, Rajeev Seth, Lillian Shum, Wen Deng, Frederick L. Hall, Zena Werb, Harold C. Slavkin	1992	163
19	Isolation, characterization, and application of monoclonal antibodies to rat tyrosine hydroxylase Journal of Neuroscience Research ·Manami Goto, Nutan T. Patel, Philip R Vulliet, Frederick L. Hall, R. M. Denney, Rong Shen, Karin N. Westlund, C. W. Abell	1989	4
20	Altered reactivity of the rat adrenal medulla Brain Research Bulletin ·Denise A. Carbonaro, Jeffrey P. Mitchell, Frederick L. Hall, Philip R Vulliet	1988	8

About Frederick L. Hall

Frederick L. Hall is a scholar working on Oncology, Biotechnology, Molecular Biology, Genetics and Cell Biology, having authored 104 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (27 papers), Virus-based gene therapy research (19 papers), Ubiquitin and proteasome pathways (13 papers), Cancer Research and Treatments (12 papers), RNA Interference and Gene Delivery (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Microtubule and mitosis dynamics (7 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Oncology (1.2k citations), Cell Biology (651 citations), Molecular Biology (2.6k citations), Biotechnology (257 citations) and Genetics (638 citations). Frederick L. Hall has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Erlinda M. Gordon, Philip R Vulliet, Richard T. Williams, Lingtao Wu, D. A. Carbonaro-Hall, W. French Anderson, Kim L. O’Neill, M Torres, Jeffrey P. Mitchell and David Warburton. Their work appears in journals such as Human Gene Therapy, Journal of Biological Chemistry, International Journal of Molecular Medicine, International Journal of Oncology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact